NTES Should I Buy
-
$
0.000
0.000(0.000%)
At close0.000(0.000%)Aft-market
ET
NetEase is a good buy right now for a beginner long-term investor with $50,000-$100,000 available. The stock has supportive technicals, strong analyst support, bullish hedge fund and congress activity, and clear event catalysts from Stock Connect inclusion and an upcoming game release. I would rate it as a buy, with the current price near a workable entry rather than waiting for a perfect dip.
NTES closed at 129.76 after a recent move above the prior close of 127.24. MACD remains positive with a histogram of 0.607, though it is contracting, which suggests momentum is still constructive but not accelerating sharply. RSI_6 at 59.52 is neutral-to-mildly bullish and does not show overbought conditions. Moving averages are converging, indicating a transition phase rather than a strong breakdown. Key levels: pivot 122.452, resistance 128.526 and 132.278, support 116.378 and 112.626. The stock is trading above the pivot and near R1, which supports a decent long-term entry.
["NetEase was included in Stock Connect, which has already helped lift the shares and should improve liquidity and market access.", "The game 'Sea of Remnants' is set for release in July, with the PC version on July 9, providing an event-driven catalyst.", "Goldman Sachs added NetEase to its APAC Conviction List and maintains a Buy rating with a $169 target.", "Morgan Stanley raised its price target to $158 and remains Overweight.", "Hedge funds are buying aggressively, with buying up 133.24% over the last quarter.", "Congress trading data shows 1 purchase and 0 sales in the last 90 days, signaling positive political/influential interest.", "The stock has a favorable medium-term trend estimate, with similar candlestick patterns implying roughly 7.99% potential over the next month."]
["MACD histogram is positive but contracting, suggesting near-term momentum is cooling.", "RSI is only neutral, so the stock is not in a strong breakout condition yet.", "Analyst changes are positive, but not based on a major upward revision in revenue expectations.", "The stock has just had a small recent decline in regular trading and is still close to overhead resistance near 132.278."]
No full financial snapshot was available, so latest-quarter revenue and earnings details cannot be assessed directly. However, Morgan Stanley noted that revenue estimates were largely unchanged while net profit estimates for 2026-2028 were raised due to stronger gross margin in Q1 and better operating expense management, which implies improving profitability trends. Since the latest quarter referenced by analysts was Q1, the recent tone suggests margin improvement rather than top-line acceleration.
Analyst sentiment is clearly bullish. Goldman Sachs added NTES to its APAC Conviction List and calls it a disciplined 'non-AI' compounder with a Buy rating and $169 target. Morgan Stanley raised its target from $154 to $158 and kept Overweight. The broader Wall Street pros view is positive: they like the company’s disciplined execution, improving margins, and long-term compounder profile. The main con is that revenue growth expectations are not being revised up sharply, so the bullish case rests more on quality, margins, and valuation support than on explosive growth.
